Avenue Therapeutics Announces Outcome of FDA Advisory Committee Meeting on IV Tramadol
NEW YORK, Feb. 15, 2022 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a…
Month: February 2022
Baudax Bio Announces 1-for-35 Reverse Stock Split
MALVERN, Pa., Feb. 15, 2022 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX) a pharmaceutical company…
Media Alert: BrainChip CEO Presents at International Investment Forum 2022
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–BrainChip Holdings Ltd (ASX: BRN, OTCQX: BRCHF, ADR: BCHPY) the world’s first…
Telix Enters Commercial Distribution Agreement for Illuccix® in Australia
MELBOURNE, Australia, Feb. 15, 2022 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the…
Coherus Names Paul Reider Chief Commercial Officer
REDWOOD CITY, Calif., Feb. 15, 2022 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (Nasdaq: “CHRS”, “the…
Revive Therapeutics Receives FDA Orphan Drug Designation for Bucillamine in the Prevention of Ischemia-Reperfusion Injury During Liver Transplantation
TORONTO, Feb. 15, 2022 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB:…
Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 8th Consecutive Year
Asserts Certara’s leadership in advancing the development and approval of new drugs for patients PRINCETON,…
HOOKIPA and Gilead Amend Collaboration and License Agreement to Develop Immunotherapies Against HIV
HOOKIPA to develop arenaviral-based therapeutic for HIV through Phase 1b clinical trial completion; Gilead has…
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2021 Financial Results
SEATTLE, Feb. 15, 2022 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a…
PacBio Announces Fourth Quarter and Fiscal Year 2021 Financial Results
MENLO PARK, Calif., Feb. 15, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) today announced financial…
Celularity Receives Orphan Drug Designation from U.S. FDA for its NK Cell Therapy CYNK-101 in Development for the First-Line Treatment of Advanced HER2/neu Positive Gastric and Gastroesophageal Junction Cancers
CYNK-101 is an investigational genetically modified NK cell therapy designed to synergize with antibody therapeutics…
VBL Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
TEL AVIV, Israel and NEW YORK, Feb. 15, 2022 (GLOBE NEWSWIRE) — VBL Therapeutics (Nasdaq:…
Carbeeza Inc. Announces Saskatchewan Launch
CALGARY, Alberta, Feb. 15, 2022 (GLOBE NEWSWIRE) — Carbeeza Inc. (the “Company”; TSX.V: AUTO) is…
ScreenPro Announces Changes to Board of Directors
Toronto, Ontario–(Newsfile Corp. – February 15, 2022) – ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF)…
Capstone Generates Record Net Income in 2021 and Increases Net Cash1 to $264.4 Million
(All amounts in US$ unless otherwise specified) VANCOUVER, British Columbia–(BUSINESS WIRE)–#CapstoneMining–Capstone Mining Corp. (“Capstone” or…
Acadia Realty Trust Announces 20% Increase in Quarterly Dividend
RYE, N.Y.–(BUSINESS WIRE)–Acadia Realty Trust (NYSE:AKR) (“Acadia” or the “Company”) today announced that its Board…
Acadia Realty Trust Reports Fourth Quarter and Full Year 2021 Operating Results
RYE, N.Y.–(BUSINESS WIRE)–Acadia Realty Trust (NYSE: AKR) (“Acadia” or the “Company”) today reported operating results…
Element Solutions Inc Declares Q1 Dividend of $0.08 Per Share
MIAMI–(BUSINESS WIRE)–Element Solutions Inc (NYSE: ESI) announced today that its board has declared a quarterly…
Granite Receives NAPA Recognition – 72 Awards and Commendations
WATSONVILLE, Calif.–(BUSINESS WIRE)–$GVA #BuildBetterTogether–Granite (NYSE:GVA) has received 72 awards and commendations from the National Asphalt…
5 Insights Into Cybersecurity For Development Of a Successful International Company
Cybersecurity is more critical than ever before. As we continue to WFH and shift to…